ARTICLE | Company News
ALK-Abello, AllerQuest deal
July 18, 2011 7:00 AM UTC
AllerQuest granted ALK-Abello exclusive, worldwide rights to commercialize its Minor Determinant Mixture (MDM) penicillin allergy skin test. AllerQuest, which is developing MDM, is eligible up to $3.5...